Chinese firms increased their reliance on science publications after the US restricted their access to proprietary information.Credit: Wang Li/VCG via Getty
Chinese companies that were barred from accessing specific US-developed technologies responded by leaning more heavily on scientific publications to fuel innovation, according to a study of patent citations and research literature published today in Science.
The researchers analyzed how Chinese firms shifted their knowledge-acquisition strategies after being added to the US Commerce Department’s Entity List, which blocks listed companies from licensing certain materials and participating in joint research and development projects. Washington says the list is meant to protect national security, and it began adding major Chinese firms in 2018 as US–China geopolitical tensions escalated.
After being listed, Chinese companies filed more patents that cited scientific papers than comparable unsanctioned firms, and they also published more research articles than their non-sanctioned counterparts, the study found.
The results highlight the “unintended consequences” of US export controls, says Cong Cao, a researcher of innovation policy at the University of Nottingham Ningbo China.
“Whether or not one supports technology controls, it is important to recognize that they can come with costs,” adds Dinsha Mistree, a political economist at Stanford University in California.
Kenneth Huang, a researcher of innovation and technology management at the National University of Singapore, cautions that although Chinese firms increased their engagement with science after the restrictions, the study cannot definitively prove that being placed on the Entity List caused the shift, as other factors may also be at play.
Science against sanctions
Previous studies have examined the impact of US sanctions on Chinese innovation, but the new analysis “uses some of the best data, as well as rigorous methods for such an analysis,” says Mistree.
To demonstrate the effect of sanctions, the researchers drew on data sets from 2010–22, including records from the China National Intellectual Property Administration (CNIPA), the article-indexing platform Web of Science and the China Stock Market and Accounting Research Database.
The team first identified broader trends: Chinese companies overall, sanctioned or not, deepened their ties to scientific research over the period. For instance, the number of CNIPA-granted patents citing at least one scientific paper grew more than 18-fold, from 5,225 in 2010 to 94,441 in 2022. Patents granted to Chinese firms by the US Patent and Trademark Office jumped more than 13-fold, from 452 to 6,071. Still, US inventors and firms remain the global leaders in linking patents to scientific knowledge.
The authors then compared Chinese companies added to the Entity List between 2010 and 2022 with non-sanctioned firms sharing similar characteristics, such as industry, ownership and location.
They found that sanctioned Chinese firms produced 72.3% more patents citing at least one scientific publication than similar non-sanctioned companies. Sanctioned firms also published 33.3% more papers indexed in the China National Knowledge Infrastructure, China’s largest academic database, and 85.2% more in Web of Science than their non-sanctioned peers.
Mistree notes that he would expect Chinese firms to increase publications and patent citations regardless of sanctions, given China’s substantial investments in science and technology during this period. “What the authors show so convincingly is that the Chinese companies that were subject to US sanctions pursued an even more intensive science and technology approach than they would have otherwise. These Chinese companies seem to double down on innovation when they are sanctioned,” he adds.

